You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NHL，19 22

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Hodgkin Lymphoma Trial in Aurora (CD19x22 CAR T Cells)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • CD19x22 CAR T Cells
  • Aurora, Colorado
    University of Colorado Hospital
Sep 1, 2022

Refractory Indolent Adult Non-Hodgkin Lymphoma Trial in Shijiazhuang (CD19 CAR-T, CD22 CAR-T, CD19+CD22 CAR-T)

Recruiting
  • Refractory Indolent Adult Non-Hodgkin Lymphoma
  • CD19 CAR-T
  • +4 more
  • Shijiazhuang, Hebei, China
    No.2 Hospital of Hebei Medical University
Nov 11, 2020

B-cell Non-Hodgkin Lymphoma (B-NHL) Trial in Austin (UCART20x22, CLLS52)

Recruiting
  • B-cell Non-Hodgkin Lymphoma (B-NHL)
  • UCART20x22
  • CLLS52
  • Austin, Texas
    Sarah Cannon - St. David South Austin Medical Center
Dec 8, 2022

B-cell NHL, CLL Trial (CARCIK-CD19)

Not yet recruiting
  • B-cell NHL
  • CLL
  • CARCIK-CD19
  • (no location specified)
May 19, 2023

B-cell Non Hodgkin Lymphoma, B-cell Chronic Lymphocytic Leukemia Trial in Milwaukee (Dose Level -1: 0.75x10^6 cells/kg

Recruiting
  • B-cell Non Hodgkin Lymphoma
  • B-cell Chronic Lymphocytic Leukemia
  • Dose Level -1: 0.75x10^6 cells/kg CAR20.19.22 cells
  • +3 more
  • Milwaukee, Wisconsin
    Medical College of Wisconsin and Froedtert Hospital
Jul 1, 2022

B-cell Non Hodgkin Lymphoma Trial in Xuzhou (regimen with BTK inhibitor +Anti-CD19 CAR T cells)

Recruiting
  • B-cell Non Hodgkin Lymphoma
  • regimen with BTK inhibitor +Anti-CD19 CAR T cells
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023

B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • CD19/CD22-bispecific CAR-T cells
  • Beijing, Beijing, China
    Liang Wang
Oct 7, 2023

Non Hodgkin Lymphoma Trial in Aurora (UCD19 CAR T Cells)

Active, not recruiting
  • Non Hodgkin Lymphoma
  • UCD19 CAR T Cells
  • Aurora, Colorado
    University of Colorado Hospital
Sep 1, 2022

Non Hodgkin's Lymphoma Trial in Beijing (Allogenic CD19-CAR-?dT cell, Fludarabine, Cyclophosphamide)

Recruiting
  • Non Hodgkin's Lymphoma
  • Allogenic CD19-CAR-γδT cell
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Jan 31, 2023

Non-hodgkin's Lymphoma Trial in Langfang (CD19+22 CAR-T cells)

Recruiting
  • Non-hodgkin's Lymphoma
  • CD19+22 CAR-T cells
  • Langfang, Hebei, China
    Hebei Yanda Ludaopei Hospital
Jan 11, 2022

Severe COVID-19 Infection in CLL or B-NHL Who Received

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
    • (no location specified)
    Apr 6, 2023

    Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Trial in Suzhou (Obinutuzumab, Zanubrutinib, Lenalidomide)

    Enrolling by invitation
    • Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
    • Suzhou, Jiangsu, China
      the First Affiliated Hospital of Soochow University
    Mar 22, 2023

    Mediastinal Lymphadenopathy, Hilar Lymphadenopathy Trial in Lucknow (EBUS-TBNA using 22 G EBUS-FNB Device OR 19 G EBUS-FNA

    Recruiting
    • Mediastinal Lymphadenopathy
    • Hilar Lymphadenopathy
    • EBUS-TBNA using 22 G EBUS-FNB Device OR 19 G EBUS-FNA needle
    • Lucknow, U P, India
      Department of Pulmonary Medicine, SGPGIMS
    Sep 15, 2022

    B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Trial in Aurora (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B-cell Non Hodgkin Lymphoma
    • CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
    • Aurora, Colorado
      Children's Hospital Colorado
    Nov 9, 2022

    B Cell Malignancies Trial in Shenzhen (bi-4SCAR CD19/22 T cells)

    Recruiting
    • B Cell Malignancies
    • bi-4SCAR CD19/22 T cells
    • Shenzhen, Guangdong, China
      Shenzhen Geno-immune Medical Institute
    Jun 21, 2022

    Non Hodgkin's Lymphoma Trial in Beijing (TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T),

    Not yet recruiting
    • Non Hodgkin's Lymphoma
    • TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
    • +2 more
    • Beijing, China
    • +2 more
    Aug 23, 2023

    Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial

    Recruiting
    • Recurrent Acute Lymphoblastic Leukemia
    • +15 more
    • Anti-CD19/CD20/CD22 CAR T-Cells
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 4, 2022

    19 and 22+ B Cell Hematologic Tumors Trial in Wuhan (Autologous CD19/CD22 Chimeric Antigen Receptor T-cells)

    Recruiting
    • 19 and 22+ B Cell Hematologic Tumors
    • 19 and 20+ B Cell Hematologic Tumors
    • Autologous CD19/CD22/CD20 Chimeric Antigen Receptor T-cells
    • Wuhan, Hubei, China
      Tongji Hospital
    Jan 11, 2023

    CAR, B Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Suzhou (ThisCART19A with Dose Level 1, ThisCART19A with Dose Level

    Recruiting
    • CAR
    • +2 more
    • ThisCART19A with Dose Level 1
    • ThisCART19A with Dose Level 2
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Jan 18, 2023

    Non-hodgkin Lymphoma,B Cell Trial in Beijing (Autologous CD19-STAR-T cell, Fludarabine, Cyclophosphamide)

    Recruiting
    • Non-hodgkin Lymphoma,B Cell
    • Autologous CD19-STAR-T cell
    • +2 more
    • Beijing, Beijing, China
    • +1 more
    Nov 21, 2022

    B-cell Acute Lymphoblastic Leukemia, B Lineage Lymphoblastic Lymphoma Trial in Philadelphia (Autologous, humanized anti-CD22 CAR

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B Lineage Lymphoblastic Lymphoma
    • Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s)
    • Autologous, humanized anti-CD19 CAR T cell therapy (huCART19)
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Jan 25, 2023

    B-cell Non Hodgkin Lymphoma Trial in Hanzhou (anti-CD19 CAR-NK)

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • anti-CD19 CAR-NK
    • Hanzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Jul 21, 2022

    Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited, r/r B-NHL Trial (ThisCART19A)

    Not yet recruiting
    • Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited, r/r B-NHL
    • (no location specified)
    Sep 9, 2022

    Advanced Malignancies Trial in Beijing (1A46 Drug Substance)

    Not yet recruiting
    • Advanced Malignancies
    • 1A46 Drug Substance
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Aug 4, 2023

    B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • Chronic Lymphocytic Leukemia
    • Cyclophosphamide injection
    • +2 more
    • Charleston, South Carolina
      Hollings Cancer Center at Medical University of South Carolina
    Jan 18, 2023